Free Trial

FibroGen (FGEN) SEC Filings & 10K Form

FibroGen logo
$9.48 -0.40 (-4.05%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$9.42 -0.06 (-0.63%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent FibroGen SEC Filings

DateFilerForm TypeView
07/14/2025
4:08 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2025
3:33 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:16 PM
FibroGen (Issuer)
Kauffman Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2025
3:17 PM
FibroGen (Issuer)
Kauffman Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:18 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
2:27 PM
ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
Form SCHEDULE 13G/A
04/25/2025
4:14 PM
FibroGen (Filer)
Form ARS
04/17/2025
4:00 PM
FibroGen (Filer)
Form PRE 14A
03/28/2025
4:20 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
8:00 AM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
8:00 AM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:15 PM
FibroGen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
6:01 PM
DeLucia David (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
6:02 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
6:03 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
4:19 PM
FibroGen (Filer)
Form 424B5
02/24/2025
4:22 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
6:00 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:49 PM
ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
Form SCHEDULE 13G/A
02/13/2025
5:24 PM
FibroGen (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SCHEDULE 13G/A
01/10/2025
5:15 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
5:16 PM
DeLucia David (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
4:01 PM
DeLucia David (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
8:15 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
7:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:00 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:52 PM
ARMISTICE CAPITAL, LLC (Filed by)
FibroGen (Subject)
Form SC 13G/A
11/12/2024
1:33 PM
FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
11:11 AM
FibroGen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/03/2024
3:05 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
7:00 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
7:00 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
7:00 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FGEN) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners